Home / People / Agnieszka Starzyńska
Portrait ofAgnieszka Starzyńska

Agnieszka Starzyńska

Head of Life Sciences and Healthcare, Poland

CMS Cameron McKenna Nabarro Olswang Pośniak i Bejm sp.k.
Varso Tower
Chmielna 69,
00-801 Warsaw
Languages English, Polish
Antitrust, Competition and Trade

Agnieszka Starzyńska is Counsel in CMS Warsaw’s Competition and Public Procurement Team.

Her competition law experience includes advising clients on issues related to anti-competitive agreements and practices, abuse of dominant position and acts of unfair competition. She has often represented clients in proceedings before the Polish Competition Authority.

Agnieszka has participated in multiple merger control notifications, including creating joint ventures as well as share and asset acquisitions.

A significant part of her experience includes advising contracting authorities and contractors on numerous public procurement projects, both on conducting the tender procedure and the preparation and effective submission of bids. Agnieszka has experience in drafting legal remedies and representing clients before the National Appeal Chamber (KIO).

more less

Relevant experience

  • A leading global manufacturer of baby food on various competition matters relating to the sale of products through both modern and traditional channels (including pricing issues, rebates, shelf space arrangements, shop exclusivity, category management, etc.).
  • A UK-based sporting goods retailer on various regulatory and commercial issues connected with opening its stores in Poland.
  • A multinational consumer products corporation on all aspects of the Polish subsidiary’s day-to-day operations, including reviewing commercial contracts and advising on promotional sales strategy.
  • One of the biggest food and drinks producers in CEE on merger control aspects of the acquisition of a Polish producer of food supplements, including preparing a merger control notification to the Polish Competition Authority and representing the client in merger control proceedings before the Authority.
  • One of the biggest developers of industrial and warehouse premises in Poland on creating a joint venture in Poland with its business partner. The advice required high-level expertise on the local markets for the rental of warehouse premises as well as relating to the real estate sector. The advice included preparing a merger control notification to the Polish Competition Authority and representing the client in merger control proceedings before the Authority.
  • An international construction company on a public procurement procedure for building, reconstructing and maintaining certain regional roads in central Poland. Providing legal assistance on preparing a complete application for participation in a competitive dialogue.
  • An international firm specialising in consulting, engineering and project management in the construction field before the National Appeal Chamber in the tender for the design of a flood protection system for a city in northern Poland.
more less

Memberships & Roles

  • Advocate -  Warsaw Bar of Advocates
  • Member - Competition Law Association in Poland
  • Member - Public Procurement Association in Poland
more less


  • Master’s Degree, Faculty of Law and Administration, University of Warsaw, Warsaw.
  • Diploma Course in English and EU law, Cambridge University and Warsaw University, Warsaw.
  • Post-graduate degree in Management in Life Sciences Sector, Lazarski University, Warsaw.
more less
Life Sciences & Healthcare

Agnieszka Starzynska is an advocate and heads the Life Sciences and Healthcare Practice in Poland. 

She specialises in life sciences, as well as commercial, competition, and consumer protection matters. A major part of her experience consists in advising entities that operate in the pharmaceutical and medical device sectors on issues related to clinical trials, developing and placing products on the market, marketing and advertising, relations with HCPs and HCOs, and products. Agnieszka takes part in internal audits and advises on compliance matters.

She also advises companies on regulatory, compliance and liability issues in relation to cannabis, cosmetics or food supplements offered for sale. 

Agnieszka provides assistance to major clients from the life sciences sector in their day-to-day business activities, including various supply, distribution and service agreements, contracts with CROs, clinical sites and investigators, and consumer communication and promotions. 

more less

Relevant experience

  • A multinational medical company on matters related to regulatory and competition laws, including an analysis of clinical trial contracts and medical device sales contracts;
  • A soft contact lens manufacturer on various regulatory and compliance matters, including advice on consumer terms, conditions and transparency of various promotional schemes for medical devices (including reimbursed medical devices);
  • A global pharmaceutical group that offers healthcare solutions in over 170 countries on the transfer to another entity of marketing authorisations for medicinal products;
  • A leading CRO on introducing a new model of cooperation with their employees, including a review of whether it could affect the role of CRO in clinical trials.
more less

Memberships & Roles

  • Advocate – Warsaw Bar of Advocates
  • Member – Competition Law Association in Poland
  • Member – Public Procurement Association in Poland
more less


  • Master’s Degree, Faculty of Law and Administration, University of Warsaw, Warsaw.
  • Diploma Course in English and EU law, Cambridge University and Warsaw University, Warsaw.
  • Post-graduate degree in Management in Life Sciences Sector, Lazarski University, Warsaw.
more less
10 key aspects of the revised EU competition law in the field of distribution...
The new Vertical Block Exemption Regulation (VBER) and the new accompanying Vertical Guidelines (VGL) were published on 10 May 2022. The new VBER will enter into force on 1 June 2022 and apply for the next twelve years. The new VBER/VGL introduce sev


Pharmaceutical advertising regulation and medical device advertising in...
1. Which laws are applicable regarding advertising of medicines and medical devices? The main act providing the legal framework for advertising of medicinal products is the Pharmaceutical Law of 6 September...
Retailer's guide to Poland
We are delighted to present the CMS Retailer’s Guide to Poland. The retail business has its own specifics that require tailor-made legal solutions. This guide provides an analysis of the key areas of...
Green/sus­tain­ab­il­ity claims and advertising and consumer greenwashing
In the era of increased environmental awareness, the spotlight on green claims has never been more intense. As consumers are concerned about global heating and ecological sustainability, they are scrutinizing products like never before, seeking eco-friendly options that align with their values. In response, businesses have responded to this concern and consumers’ purchase interest, with brand-owners increasingly highlighting the benign or even beneficial effects their products and services have on the environment fostering a surge in green marketing initiatives. Yet, amidst this push for sustainability, the risk of being accused of greenwashing is omnipresent. As environmental characteristics of products and services are highly technical and the understanding of the various concepts involved is continuously changing, en­vir­on­ment­al/sus­tain­ab­il­ity claims raise a significant risk of confusing and misleading consumers. Many companies have fallen foul of advertising standards in this area recently. Given the high sensitivity of environmental claims and the reputational damage that can result from allegations of greenwashing, it is particularly important to make sure environmental claims are compliant. By ensuring truthful, accurate and unambiguous information is always given to the consumers, companies can avoid the risks and build a reputation for authenticity in their sustainability advertising and communications. CMS guides companies through the maze of regulations and case law and advise on the steps a company can take to ensure their advertising is not only compliant but also authentic and impactful. The priority questions we address are: Which green claims are likely to raise litigation or regulatory enforcement risks?What can businesses do to mitigate these risks?What are the likely claims/en­force­ment that could arise?Who is likely to make a claim?What are the risks in the event of a violation or a complaint? What future regulatory measures are expected and what companies have to do now to be prepared? We offer various solutions to help you be compliant and avoid accusations of greenwashing: Sustainability claim checks including regulatory risk matrix as well as litigation: evaluating the planned claims and mapping their risk as well as developing compliant marketing strategies and claims custom-tailored to your business's unique pro­file;Sus­tain­ab­il­ity-re­lated litigation: providing comprehensive support in legal disputes in the area of advertising with environmental claims;Training sessions: to empower your legal, compliance and sustainability as well as advertising teams with in-depth knowledge of sustainability risks and mitigation strategies; andBoard packs: to equip your directors/board members with actionable insights into greenwashing risks, ensuring they steer the company toward sustainable strategies with confidence and integrity.  For an initial conversation on how we can support you on greenwashing risk, please reach out to the lawyers listed on this page or to your usual CMS contact.
Cannabis law and legislation in Poland
Medical use Polish legislation does not generally allow the growing of cannabis that contains more than 0.3% THC in flowering or fruiting tops of plants from which the resin has not been removed (Non-Fibrous...
Digital health apps and telemedicine in Poland
Digital Health Apps/Software 1. How is the software within digital health apps classified in your jurisdiction, and what regulation(s) apply? 1.1 Is it considered a “medical device” or a “product”...
Poland adopts new regulation regarding advertisement of medical devices
After months of preparation, Poland has approved a new Regulation regarding advertisement of medical devices, which will come into force on 13 May 2023. In addition to the statutory requirements on advertising...
CEE Expert Guide on the reimbursement of orphan drugs in Poland
1. Is there a legal definition of orphan drugs under your law? Polish law does not provide a separate definition of orphan drugs. Instead, Polish law simply refers to Regulation 141/2000 of the European...
New environmental regulations in CEE: revolution or evolution for consumer...
The consumer sector is currently facing a huge pressure from the regulators when it comes to environmental issues. New requirements arise with respect to each stage of the products life cycle: from designing...
Polish high court provides a new favourable ruling for home-delivery sale...
In a recent judgment, Poland's Supreme Administrative Court (NSA) gives cause for optimism for anyone who is carrying out online alcohol sales or considering such sales. The NSA's ruling (ref. II GSK...
Poland amends Act on Payment Delays – what changes will enterprises face?
On 14 November 2022, the Amended Act on Payment Delays was signed by the President of the Republic of Poland, which introduces numerous changes to the current legislation, applicable to, among other things...
No more hidden advertising of products by influencers? Re­com­mend­a­tions...
As part of an investigation into reports that Polish consumers were being misled over social media, Poland's Office of Competition and Consumer Protection (UOKiK) issued Recommendations pertaining to...
CMS advises Brodvik AB on the sale of SITS
International law firm CMS has advised Brodvik AB on the sale of 100% of shares in SITS sp z o.o. to Actona Group A/S. Brodvik AB is a Swedish wholesaler of furniture, carpets and lighting equipment...